News | January 28, 2014

ReCor Medical Advances Ultrasound-Based Renal Denervation System

ReCor Medical Paradise System Renal Denervation RDN Therapy Hypertension
January 28, 2014 — ReCor Medical advanced its Paradise System for renal denervation (RDN) for treatment resistant hypertension (HTN).
 
The company received CE marking for the latest generation of its ultrasound-based renal denervation system. Patients were treated with the system in December 2013 at the Universitats–Herzzentrum, Bad Krozingen, Germany by Prof. Thomas Zeller, M.D. and Elias Noory, M.D.
 
"The initial procedures with the Paradise System highlighted the generator's ability to automatically customize energy delivery based on the patient's artery size while maintaining a consistent level of cooling protection," Zeller and  Noory said.
 
Drs. Nicolas Van Mieghem and Joost Daemen, Erasmus Medical Center in Rotterdam, the Netherlands, used for the first time ReCor's Radiance catheter line, which is 5 French and rapid-exchange compatible to be introduced in the radial artery.
 
"Last Friday's procedures using the new Radiance catheter with access via the radial artery marks a significant new approach to making the RDN procedure quicker, safer and potentially more cost-effective for hospitals and patients," they said. “This system's radial artery access and 10 second ablation time should allow us to treat a patient in a minimally invasive way within 30 minutes, and then let that patient go home the same day."
 
The Paradise System uses radial ultrasound as its energy source with water-based convective cooling.
 
For more information: www.recormedical.com

Related Content

Sponsored Content | Videos | Cath Lab | October 24, 2018
Michael Flaherty, M.D., discusses a study published in Circulation Research which finds that use of hemodynamic suppo
Philips Showcases Integrated Solutions for Cardiovascular Care at TCT 2018
News | Cath Lab | September 20, 2018
At the Transcatheter Cardiovascular Therapeutics (TCT) annual meeting, Sept. 21–25 in San Diego, Philips is showcasing...
Sponsored Content | Videos | Cath Lab | September 19, 2018
William O’Neill, M.D., outlines his recent clinical publication of AMICS patients from the Impella Quality (IQ) datab
A complex PCI case to revascularize a chronic total occlusion (CTO) at Henry Ford Hospital in Detroit. Complex PCI and CHIP cases are increasing patient volumes in the cath lab and using a minimally invasive approach in patients who otherwise would have been sent for CABG. Pictured is Khaldoon Alaswad, M.D. DAIC staff photo by Dave Fornell

A complex PCI case to revascularize a chronic total occlusion (CTO) at Henry Ford Hospital in Detroit. Complex PCI and CHIP cases are increasing patient volumes in the cath lab and using a minimally invasive approach in patients who otherwise would have been sent for CABG. Pictured is Khaldoon Alaswad, M.D. (right) who is proctoring a fellow in treating CTOs.

Feature | Cath Lab | September 13, 2018 | Artur Kim, Kamran Zamanian
Coronary artery disease (CAD) is a multifaceted disease that demands various approaches in terms of diagnosis and tre
Videos | Cath Lab | August 13, 2018
Jeffrey Schussler, M.D., FACC, FSCAI, FSCCT, FACP, interventional cardiologist at Baylor Scott White Heart and Vascul
Shockwave Launches Coronary Intravascular Lithotripsy in Europe
News | Cath Lab | May 30, 2018
Shockwave Medical recently announced the European commercial availability of Intravascular Lithotripsy (IVL) for...
FFR software on the GE Centricity CVIS. A trial from the 2018 EuroPCR meeting showed FFR improves long-term outcomes.
News | Cath Lab | May 29, 2018
May 29, 2018 — Ongoing controversy exists regarding the role of percutaneous coronary intervention (PCI) for stable c
Overlay Init